These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23430528)
1. Neonatal Bone Marrow Transplantation in MPS IIIA Mice. Lau AA; Shamsani NJ; Winner LK; Hassiotis S; King BM; Hopwood JJ; Hemsley KM JIMD Rep; 2013; 8():121-32. PubMed ID: 23430528 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice. Lau AA; Hannouche H; Rozaklis T; Hassiotis S; Hopwood JJ; Hemsley KM Exp Neurol; 2010 Oct; 225(2):445-54. PubMed ID: 20673764 [TBL] [Abstract][Full Text] [Related]
3. An Engineered Douek AM; Amiri Khabooshan M; Henry J; Stamatis SA; Kreuder F; Ramm G; Änkö ML; Wlodkowic D; Kaslin J Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073041 [TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction. Magat J; Jones S; Baridon B; Agrawal V; Wong H; Giaramita A; Mangini L; Handyside B; Vitelli C; Parker M; Yeung N; Zhou Y; Pungor E; Slabodkin I; Gorostiza O; Aguilera A; Lo MJ; Alcozie S; Christianson TM; Tiger PMN; Vincelette J; Fong S; Gil G; Hague C; Lawrence R; Wendt DJ; Lebowitz JH; Bunting S; Bullens S; Crawford BE; Roy SM; Woloszynek JC J Biol Chem; 2022 Dec; 298(12):102625. PubMed ID: 36306823 [TBL] [Abstract][Full Text] [Related]
5. Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease. Saville JT; Derrick-Roberts ALK; McIntyre C; Fuller M Hum Gene Ther; 2021 Apr; 32(7-8):420-430. PubMed ID: 33339477 [TBL] [Abstract][Full Text] [Related]
6. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA. Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group. Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768 [TBL] [Abstract][Full Text] [Related]
14. SGSH gene transfer in mucopolysaccharidosis type IIIA mice using canine adenovirus vectors. Lau AA; Hopwood JJ; Kremer EJ; Hemsley KM Mol Genet Metab; 2010 Jun; 100(2):168-75. PubMed ID: 20231109 [TBL] [Abstract][Full Text] [Related]
15. Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA. Rozaklis T; Beard H; Hassiotis S; Garcia AR; Tonini M; Luck A; Pan J; Lamsa JC; Hopwood JJ; Hemsley KM Exp Neurol; 2011 Jul; 230(1):123-30. PubMed ID: 21515264 [TBL] [Abstract][Full Text] [Related]
16. Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector. Bobo TA; Samowitz PN; Robinson MI; Fu H Mol Ther Methods Clin Dev; 2020 Dec; 19():474-485. PubMed ID: 33313335 [TBL] [Abstract][Full Text] [Related]
17. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Hemsley KM; Hopwood JJ Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885 [TBL] [Abstract][Full Text] [Related]
18. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome. Lau AA; King BM; Thorsen CL; Hassiotis S; Beard H; Trim PJ; Whyte LS; Tamang SJ; Duplock SK; Snel MF; Hopwood JJ; Hemsley KM J Inherit Metab Dis; 2017 Sep; 40(5):715-724. PubMed ID: 28451919 [TBL] [Abstract][Full Text] [Related]